aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to advance the field of surgical oncology, Onkos Surgical is a privately-held company dedicated to providing innovative technology and solutions for surgical oncologists. The company focuses on developing specialized implants and instruments tailored for tumor and revision orthopedic surgeries, including patient-specific 3D printed pelvic reconstruction systems. Onkos Surgical aims to improve patient outcomes by addressing the unique challenges faced in musculoskeletal oncology.
Notable achievements include receiving the first FDA De Novo approval for an antibacterial coating on tumor and revision orthopedic implants, as well as FDA clearance for their 3D printed, patient-specific pelvic reconstruction system. The company has also expanded its capabilities in pediatric musculoskeletal oncology and established a new Manufacturing and Innovation Center. These milestones underscore Onkos Surgical's impact on enhancing surgical oncology practices and improving patient care.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Surgical Implants
Technology
3d Printing
Tags
Biotech, Healthtech
Model Types
Hardware
Revenue Type(s)
Enterprise, Government
Customer Type(s)
Americas
When was Onkos Surgical founded?
Onkos Surgical was founded in 2015.
Where is Onkos Surgical’s headquarters located?
Onkos Surgical’s headquarters is located in Parsippany-Troy Hills, NJ, US.
When was Onkos Surgical’s last funding round?
Onkos Surgical’s most recent funding round was for $26.5M (USD) in June 2022.
How many employees does Onkos Surgical have?
Onkos Surgical has 89 employees as of Feb 5, 2024.
How much has Onkos Surgical raised to-date?
As of July 05, 2023, Onkos Surgical has raised a total of $85.2M (USD) since Jun 16, 2022.
Add Comparison
Total Raised to Date
$85.2M
USD
Last Update Jun 16, 2022
Last Deal Details
$26.5M
USD
Jun 16, 2022
Series Unknown
Total Employees Over Time
89
As of Feb 2024
Onkos Surgical Address
77 East Halsey Road
Parsippany-Troy Hills,
New Jersey
07054
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts